Xtalks keeps its audience informed on the latest health industry economics through its commercialization & HEOR webinars. These webinars cover topics like health economic assessments, pharmacoeconomics, access challenges, strategic alliances and drug modeling for commercialization strategies.

Emerging Trends
Our webinars spotlight new trends such as using real-world evidence (RWE) to expedite drug approvals. RWE adds valuable data alongside clinical trials. For instance, a drug may earn marketing authorization sooner with robust Phase II real-world data. This approach can reduce the need for later-stage trials, speed up market entry and ultimately benefit patients — especially those with unmet needs, like rare genetic diseases.

Strategies and Partnerships
We explore how RWE boosts cost-effectiveness by cutting expensive late-stage trials. Our sessions also cover how RWE can support therapy expansion into other indications, bypassing additional trials. Early regulator communication is critical, and our webinars offer guidance on seeking scientific advice and building strategic industry partnerships.

Digital Innovations
Digital technologies drive innovative solutions in drug development, large-scale manufacturing and commercialization. Our webinars explain how digitization in manufacturing builds efficiency, ensures GMP compliance and maintains critical quality attributes.

Stay Updated
Xtalks’ commercialization & HEOR webinars help industry professionals stay current with evolving policies and guidelines from local and global health authorities. Gain strategic insights and learn how to increase product value by registering for our upcoming webinars.